Clinical consequences of defects in B-cell development.
Clinical consequences of defects in B-cell development.
复制标题
DOI:
10.1016/j.jaci.2010.02.018
复制
发表时间:
2010-04
影响因子:
14.2
通讯作者:
Schroeder, Harry W., Jr.
中科院分区:
文献类型:
--
作者:
Vale, Andre M.;Schroeder, Harry W., Jr.
Abnormalities in humoral immunity typically reflect a generalized or selective failure of effective B cell development. The developmental processes can be followed through analysis of cell surface markers such as IgM, IgD, CD10, CD19, CD20, CD21, and CD38. Early phases of B cell development are devoted to the creation of immunoglobulin and testing B cell antigen receptor signaling. Failure leads to the absence of B cells and immunoglobulin in the blood from birth. As the developing B cells begin to express a surface B cell receptor, they become subject to negative and positive selection pressures and increasingly depend on survival signals. Defective signalling can lead to selective or generalized hypogammaglobulinemia even in the presence of normal numbers of B cells. In the secondary lymphoid organs, some B cells enter the splenic marginal zone where pre-activated cells lie ready to rapidly respond to T-independent antigens, such as the polysaccharides that coat some microorganisms. Other cells enter the follicle and, with the aid of cognate follicular T cells, divide to help form a germinal center after their interaction with antigen. In the germinal center, B cells can undergo the processes of class switching and somatic hypermutation. Failure to properly receive T cell signals can lead to Hyper IgM syndrome. B cells that leave the germinal center can develop into memory B cells, short lived plasma cells, or long lived plasma cells. The latter ultimately migrate back to the bone marrow where they can continue to produce protective antigen-specific antibodies for decades.
登录
查看更多内容
DOI:
10.1084/jem.20070264
发表时间:
2007-09-03
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
通讯作者:
--
影响因子:
64.5
作者:
BEREK, C;BERGER, A;APEL, M
通讯作者:
APEL, M
影响因子:
9.8
作者:
Conley, ME;Mathias, D;Rohrer, J
通讯作者:
Rohrer, J
影响因子:
32.4
作者:
Fu, C;Turck, CW;Chan, AC
通讯作者:
Chan, AC
DOI:
10.1084/jem.20072682
发表时间:
2008-08-04
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ehrhardt GR;Hijikata A;Kitamura H;Ohara O;Wang JY;Cooper MD
通讯作者:
Cooper MD